Trial Profile
A Randomized, Open-label, Single Dose, Replicate Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Amlodipine/chlortalidone/telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Yuhan
- 14 Jan 2019 Status changed from not yet recruiting to completed.
- 14 Sep 2018 New trial record